These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16437213)

  • 21. Adjusting transgene expression levels in lymphocytes with a set of inducible promoters.
    Danke C; Grünz X; Wittmann J; Schmidt A; Agha-Mohammadi S; Kutsch O; Jäck HM; Hillen W; Berens C
    J Gene Med; 2010 Jun; 12(6):501-15. PubMed ID: 20527043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector.
    Aurisicchio L; Bujard H; Hillen W; Cortese R; Ciliberto G; La Monica N; Palombo F
    Gene Ther; 2001 Dec; 8(24):1817-25. PubMed ID: 11821934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a doxycycline-inducible lentiviral plasmid with an instant regulatory feature.
    Yang T; Burrows C; Park JH
    Plasmid; 2014 Mar; 72():29-35. PubMed ID: 24727543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of wild-type and noncleavable Fas ligand by tetracycline-regulated adenoviral vectors to limit intimal hyperplasia in vascular lesions.
    Mano T; Luo Z; Suhara T; Smith RC; Esser S; Walsh K
    Hum Gene Ther; 2000 Aug; 11(12):1625-35. PubMed ID: 10954897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy.
    Aoki K; Akyürek LM; San H; Leung K; Parmacek MS; Nabel EG; Nabel GJ
    Mol Ther; 2000 Jun; 1(6):555-65. PubMed ID: 10933980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR.
    Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC
    Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing regulatable gene expression using adenoviral vectors.
    Lee YB; Glover CP; Cosgrave AS; Bienemann A; Uney JB
    Exp Physiol; 2005 Jan; 90(1):33-7. PubMed ID: 15542617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FasL gene therapy: a new therapeutic modality for head and neck cancer.
    ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
    Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.
    Gu J; Zhang L; Huang X; Lin T; Yin M; Xu K; Ji L; Roth JA; Fang B
    Oncogene; 2002 Jul; 21(31):4757-64. PubMed ID: 12101414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.
    Pluta K; Diehl W; Zhang XY; Kutner R; Bialkowska A; Reiser J
    BMC Biotechnol; 2007 Jul; 7():41. PubMed ID: 17634114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop.
    Woraratanadharm J; Rubinchik S; Yu H; Fan F; Morrow SM; Dong JY
    Gene Ther; 2004 Sep; 11(18):1399-407. PubMed ID: 15229631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tetracycline-regulated adenoviral expression system for in vivo delivery of transgenes to lung and liver.
    Tietge UJ; Kozarsky KF; Donahee MH; Rader DJ
    J Gene Med; 2003 Jul; 5(7):567-75. PubMed ID: 12825196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus.
    Fecker LF; Schmude M; Jost S; Hossini AM; Picó AH; Wang X; Schwarz C; Fechner H; Eberle J
    Exp Dermatol; 2010 Aug; 19(8):e56-66. PubMed ID: 19725869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration.
    Yao X; Yoshioka Y; Morishige T; Eto Y; Narimatsu S; Mizuguchi H; Mukai Y; Okada N; Nakagawa S
    Biol Pharm Bull; 2010; 33(6):1073-6. PubMed ID: 20522982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoviral vectors encoding tumor necrosis factor-alpha and FasL induce apoptosis of normal and tumoral anterior pituitary cells.
    Candolfi M; Jaita G; Pisera D; Ferrari L; Barcia C; Liu C; Yu J; Liu G; Castro MG; Seilicovich A
    J Endocrinol; 2006 Jun; 189(3):681-90. PubMed ID: 16731798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenoviral vector-mediated gene therapy in the mouse lung: no role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells.
    Chirmule N; Moffett J; Dhagat P; Tazelaar J; Wilson JM
    Hum Gene Ther; 1999 Nov; 10(17):2839-46. PubMed ID: 10584929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain.
    Liu B; Wang S; Brenner M; Paton JF; Kasparov S
    J Gene Med; 2008 May; 10(5):583-92. PubMed ID: 18324737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
    Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
    Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
    Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
    Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.